potassium status of patients with heart failure
|
|
- Eileen Sutton
- 5 years ago
- Views:
Transcription
1 Pstgraduate Medical Jurnal (June 1978) 54, The effects f ptassium supplements, spirnlactne r amilride n the ptassium status f patients with heart failure C. DAVIDSON M.A., M.B., M.R.C.P. D. B. MORGAN M.D., M.R.C.Path. L. BURKINSHAW B.Sc., Ph.D. Departments f Medicine, Medical Physics and Chemical Pathlgy, General Infirmary, Leeds Summary xtra ptassium supplements, spirnlactne r amilride were given fr 5 mnths t frty-nine patients with heart failure wh were taking fursemide and were in a steady state. Plasma ptassium increased with all three treatments but there was n significant increase in ttal bdy ptassium r red cell ptassium. These findings tgether with ther studies suggest that patients with heart failure taking diuretics d nt have a significant depletin f bdy ptassium. Intrductin Ptassium depletin is generally accepted as ne f the hazards f lng-term treatment with ptent diuretics in patients with heart failure, and these patients are therefre usually als given either ptassium supplements r ne f the ptassiumsparing diuretics. The authrs recently measured the ttal bdy ptassium (TBK) f patients with chrnic heart disease with a ttal bdy radiatin cunter (Davidsn et al., 1976). The TBK in the patients with heart disease was nt significantly different frm the TBK in a grup f healthy subjects. Mrever, amng the patients with heart disease there was n difference between thse wh were taking diuretics and thse wh were nt, and in thse n diuretics there was n difference between thse taking small dses f ptassium supplements and thse taking large dses. These findings cntrasted with previus reprts in the literature, and did nt supprt the view that ptassium depletin was a cmplicatin f lng-term diuretic therapy. Nevertheless, it culd be argued that a crss-sectinal study is an insensitive apprach since it depends n the cmparisn f a grup f patients with a grup f cntrls; a mre sensitive apprach wuld be t study serial changes in individual patients. Ideally such a study shuld be carried ut frm the time the patients start diuretics Address fr reprint requests: Prfessr D. B. Mrgan, Department f Chemical Pathlgy, The General Infirmary, Leeds. but this is difficult lgistically and as far as the authrs knw it has nt been dne. Alternatively ne can attempt t crrect any deficit in bdy ptassium in patients already established n treatment by giving extra ptassium supplements r a ptassium-retaining diuretic. If ptassium depletin is present, these changes in treatment shuld cause an increase in TBK, even in a patient whse TBK is reduced but still lies within the nrmal range. Surprisingly this apprach has nly rarely been used in heart failure (De Deuchaisnes, Busset and Cllet, 1961; White, 197; Davidsn and Gillebrand, 1973). A grup f patients with heart failure have been studied wh had been taking a cnstant dse f fursemide and ptassium supplements fr at least 6 mnths. The ptassium supplements were either increased t 48 mml/day r replaced by spirnlactne r amilride. The dse f fursemide was kept cnstant thrughut the study. The ptassium status f the three treatment grups was assessed at mnthly intervals fr 5 mnths after the change f treatment. Patients The patients in this study came frm a larger crss-sectinal study f patients with heart failure (Davidsn et al., 1976). Sixty-six patients wh agreed t jin the study were allcated t ne f three treatment grups using randm tables. Six patients were subsequently excluded frm the ptassium grup because they were already taking 48 mml f ptassium r mre per day. leven patients did nt finish the trial; six required an increased dse f diuretic, three defaulted and tw died frm mycardial infarctin. The final analysis was therefre based n a ttal f frty-nine patients; thirteen patients had their ptassium supplements increased t 48 mml/day; sixteen tk spirnlactne (1 mg/day) and twenty tk amilride (2 mg/day). The patients in the spirnlactne and amilride grups stpped their ptassium supplements. The increase in ptassium supplements in /78/6-45 $ The Fellwship f Pstgraduate Medicine Pstgrad Med J: first published as /pgmj n 1 June Dwnladed frm n 13 August 218 by guest. Prtected by
2 46 the ptassium grup (given Slw K) was n average 25 mml/day (range 8-4 mml/day). Clinical details f the patients are shwn in Table 1. The patients were seen at least nce, but usually twice, befre their treatment was changed and then five times at mnthly intervals. At each visit the patients were asked abut symptms and the side effects f treatment, and their TBK, plasma ptassium, red cell ptassium and 24-hr urine ptassium excretin were measured. Details f these techniques are given elsewhere (Davidsn et al., 1976). Chest X-rays were taken at the beginning and end f the study. The ttal duratin f the study was 18 mnths. Results Table 2 shws that the plasma, electrlytes, urea and creatinine were the same n average in the three grups befre treatment was changed. The average TBK differed between the grups, but there were als differences in age and weight. The bserved TBK was cmpared with the TBK predicted frm sex, age, weight, height and skin fld thicknesses (Davidsn et al., 1976). There was a small apparent deficit f TBK in each grup (25, 79 and 183 mml respectively). Nne f the patients had any clinical r radilgical deteriratin during the study. Twelve patients (tw n ptassium supplements, three n spirnlactne, seven n amilride) had transient epigastric discmfrt r nausea when they changed treatment. In three patients (tw spirnlactne, ne amilride) these symptms persisted until the end f the study. Tw patients in the spirnlactne grup had persistent gynaecmastia. Figure 1 shws the changes in plasma ptassium, urinary ptassium excretin and TBK in the three grups f patients. The results have been calculated as the difference frm the mean value befre the treatment was changed. Plasma ptassium increased at first in all grups by.1-.2 mml/l but the rise was nt sustained in the ptassium grup. Urinary ptassium excretin increased by the expected 2 mml/day in the ptassium grup and decreased by the same amunt in the ther tw grups wh stpped their ptassium supplements when they changed treatment. There were n significant changes in TBK. In rder t summarize the changes in the ther measurements, the values befre treatment have been cmpared with the values at the furth mnth f treatment; the values at 4 mnths were representative f the values in the latter part f the study. There were small falls in bdy weight and bld pressure; the fall in weight was significant nly in the ptassium grup (P<.5), and the fall in bld pressure was significant nly in the spirnlactne C. Davidsn, L. Burkinshaw and D. B. Mrgan a. 'O mcd 2-2 ~: l -1 [-.A ll Mnths f tretment FIG. 1. The changes in plasma ptassium, urinary ptassium and ttal bdy ptassium (TBK) in the three grups f patients. Results calculated as the difference frm the mean value befre the treatment was changed: A - patients given ptassium supplements. - patients given spirnlactne. * - patients given amilride. grup (P<'1). There was a significant fall in plasma sdium (P< 1) and a rise in bicarbnate (P<-1) in the spirnlactne grup. There was a rise in bld urea in the amilride grup (P<.1) but n significant change in the plasma creatinine. Red cell ptassium did nt change in any grup. Discussin This lngitudinal study was undertaken because the previus crss-sectinal study f patients with heart failure had failed t detect large ptassium deficits and was therefre at variance with numerus previus reprts (Davidsn et al., 1976). The patients in the present study had apparent deficits which were similar t thse in the previus study (5-2 mml). Hwever, extra ptassium, spirnlactne r amilride failed t raise the ttal bdy r red cell K despite a rise in plasma ptassium, which makes it unlikely they were ptassium depleted. There have been several similar studies in heart failure in which either extra ptassium r a ptassium-sparing diuretic has been added t the diuretic Pstgrad Med J: first published as /pgmj n 1 June Dwnladed frm n 13 August 218 by guest. Prtected by
3 Ptassium status in heart failure la la c C). t- Q) c) a) r_. C) -1-- u) cn.4 (A 3 rọ 5: t 3r 3 ~4 f =rx b 4 " U _ - eeo r- e~t' en, c'4 eq n t,", rrr_r - _ c _m, C-._ 47 Pstgrad Med J: first published as /pgmj n 1 June Dwnladed frm X C) 2It O - Z_.22) (A 2 Q a (A -a.- au v, _l O \D 'IC O aci t Cd CI -i C r n 13 August 218 by guest. Prtected by
4 ii II O a a> C) C a c. _bdew O I-,.,, w I 6 Sl;pi W \ u' 6u -s<- >,- 3 3 v. ^_ O-- r >X AW wx. ^ ^ ^ UjO - O O ON v ^B \ḡo _ wo 3.O w - - O) -C _ 6 ^ w9w ^ 9 ^ W _2 _ O ~-a ea t _ V.,_. - \3\ -JkI k)..). -1\O \u. ; ~~~,, ~~~m ~~ Y~~~~ ~ LA H I -9 ct. a Pstgrad Med J: first published as /pgmj n 1 June Dwnladed frm n 13 August 218 by guest. Prtected by
5 regime. Mst studies have used exchangeable ptassium (Ke) as a measure f bdy ptassium. They have ften invlved small numbers f patients fllwed fr relatively shrt perids, and the results have been cnflicting. Three grups have studied the effect f ptassium supplements. De Deuchaisnes et al. (1961) gave eight patients 4-12 mml/day f extra ptassium fr ne t three weeks. The average Ke did nt change and the extra ptassium was excreted in the urine. White (197) gave seven patients with heart failure and an apparent ptassium deficit 48 mml/ day f extra ptassium fr 4 weeks. There was n change in plasma ptassium but Ke increased by an average f 2 mml. Dwn, Plak and Ra (1972) gave fur patients with heart failure and an apparent ptassium deficit 48 mml/day fr 2 mnths. There was n change in plasma ptassium r Ke. The results frm studies f ptassium-sparing diuretics have been equally incnclusive. Davidsn and Gillebrand (1973) gave amilride fr 6 mnths t twenty-fur patients with heart failure stabilized n fursemide. There was a sustained rise in plasma ptassium; Ke initially rse by 32 mml but at 6 mnths was n greater than befre the change in treatment. Nichlls, spiner and Hughes (1976) studied eleven patients with heart failure fr 2 mnths after substituting amilride fr ptassium supplements. There was n change in plasma ptassium r Ke. White (1969) reprted that spirnlactne prevented any fall in Ke in patients taking fursemide; Friis (1972) cncluded that it did nt increase Ke in patients with heart failure. There are several studies shwing that spirnlactne increases plasma ptassium (Gerge, Breckenridge and Dllery, 1973). The present study is thus in agreement with mst reprts frm the literature. xtra ptassium supplements r ptassium-sparing diuretics can increase plasma ptassium, but they d nt influence bdy ptassium. These drugs may therefre be unnecessary t maintain bdy ptassium in heart failure during lng-term diuretic treatment. Lawsn Bddy and Gray (1976) gave twenty-ne patients with heart failure diuretics but n ptassium supplements fr a year. There was a small fall in plasma ptassium but n change in TBK. Nevertheless, the general view is that patients with heart failure are depleted f ptassium and that the depletin is related t the use f ptent diuretics (Leading Article, 1977). This view seems t be based n the numerus reprts f lw K, in patients with heart failure taking diuretics and the demnstratin that these diuretics can increase the urine ptassium and lwer the plasma ptassium. The authrs have recently reviewed all published data n exchangeable Ptassium status in heart failure 49 ptassium in patients with heart disease (Mrgan, Burkinshaw and Davidsn, 1978). Althugh there was an apparent deficit f2-3% fbdy ptassium, this deficit was n greater in the patients taking diuretics than in thse wh were nt, and culd be explained by the muscle wasting which happens in chrnic heart disease. The findings in the present study, the authrs' previus study (Davidsn et al., 1976), the study f Lawsn et al. (1976) and the authrs' review f the literature (Mrgan et al., 1978) lead the authrs t cnclude that there is n true ptassium depletin in patients with heart disease, even thse taking diuretics. The nly reasn fr treating patients with ptassium supplements r ptassium-sparing agents is t prevent r treat a lw plasma ptassium. Acknwledgments We are grateful t Dr W. Whitaker, Dr D. Smith and Mr M. Inescu wh allwed us t study their patients; Mrs D. Davidsn wh had a majr respnsibility in the rganizatin f the study; Miss D. W. Krupwicz wh made the TBK measurements; and Miss S. Hassam and the many staff f the Departments f Chemical Pathlgy wh made the chemical measurements. The study was supprted in part by a grant frm G. D. Searle. References DAVIDSON, C. & GILLBRAND, I.M. (1973) Use f amilride as a ptassium cnserving agent in severe cardiac disease. British Heart Jurnal, 35, 456. DAVIDSON, C., MCLACHLAN, M.S.F., BURKINSHAW, L. & MORGAN, D.B. (1976) ffect f lng-term diuretic treatment n bdy-ptassium in heart disease. Lancet, i, 144. D DUCHAISNS, C.N., BUSST, R. & COLLT, R.A. (1961) xchangeable ptassium in wasting, amytrphy, heart disease, and cirrhsis f the liver. Lancet, ii, 681. DOWN, P.F., POLAK, A. & RAO, R. (1972) Fate f ptassium supplements in six utpatients receiving lng-term diuretics fr edematus disease. Lancet, ii, 721. FRIIS, TH. (1972) In: xtrarenal Activity f Aldsterne and its Antagnists xcerpta Medica, Amsterdam, 35. GORG, C.F., BRCKNRIDG, A.M. & DOLLRY, C.T. (1973) Cmparisn f the ptassium-retaining effects f amilride and spirnlactne in hypertensive patients with thiazide-induced hypkalaemia. Lancet, ii, LAWSON, D.H., BODDY, K. & GRAY, J.M.B. (1976) Ptassium supplements in patients receiving lng-term diuretics fr edema. Quarterly Jurnal f Medicine, 45, 469. LADING ARTICL (1977) Ptassium in heart failure. British Medical Jurnal, 1, 469. MORGAN, D.B., BURKINSHAW, L. & DAVIDSON, C. (1978) Ptassium depletin in heart failure and its relatin t lng-term treatment with diuretics: a review f the literature. Pstgraduate Medical Jurnal, 54, 72. NICHOLLS, M.G., SPINR,.A. & HUGHS, H. (1976) ffect f ptassium-sparing diuretics n the renin-angitensin-aldsterne system and ptassium retentin in heart failure. British Heart Jurnal, 38, 125. WHIT, R.J. (1969) The bdy electrlytes in heart failure and in systematic hypertensin. M.D. thesis, University f Cambridge. WHIT, R.J. (197) ffect f ptassium supplements n the exchangeable ptassium in chrnic heart disease. British Medical Jurnal, 3, 141. Pstgrad Med J: first published as /pgmj n 1 June Dwnladed frm n 13 August 218 by guest. Prtected by
M.R.C.Path. causes to the raised plasma urea in patients admitted
Pstgradcuate Medical Jurnal (January 1979) 55, 1-14 The cause f the raised plasma urea f acute heart failure R D THOMAS MRCP D B MORGAN MRCPath ALISON NWILL AIMLS Departments f Cardilgy and Chemical Pathlgy,
More informationDATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS
DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 216 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS This briefing has been specifically prepared fr the Ministry f Health t prvide infrmatin frm this
More informationM.J. Guthriel, D.G. Wagner2
EFFECT OF SUPPLEMENTAL PROTEIN OR GRAIN ON INTAKE AND UTILIZATION OF MEDIUM QUALITY PRAIRIE HAY BY STEERS M.J. Guthriel, D.G. Wagner2 and D.C. Weakley3 Stry in Brief Sixteen 1,053 lb tw-year-ld Herefrd
More informationFrequently Asked Questions: IS RT-Q-PCR Testing
Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld
More informationMEDICATION GUIDE Pioglitazone and Metformin Hydrochloride (PYE o GLI ta zone and met FOR min HYE-droe- KLOR-ide)Tablets, USP
MEDICATION GUIDE Piglitazne and Metfrmin Hydrchlride (PYE GLI ta zne and met FOR min HYE-dre- KLOR-ide)Tablets, USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride
More informationMEDICATION GUIDE Pioglitazone (pie-oh-glit-ah-zohn) and Metformin (met-fore-min) Hydrochloride Tablets USP
MEDICATION GUIDE Piglitazne (pie-h-glit-ah-zhn) and Metfrmin (met-fore-min) Hydrchlride Tablets USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride tablets
More informationA Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.
SAMPLE INFORMED CONSENT A Phase I Study f CEP-701 in Patients with Refractry Neurblastma NANT (01-03) A New Appraches t Neurblastma Therapy (NANT) treatment prtcl. The wrd yu used thrughut this dcument
More informationPublic consultation on the NHMRC s draft revised Australian alcohol guidelines for low-risk drinking
Public cnsultatin n the NHMRC s draft revised Australian alchl guidelines fr lw-risk drinking Recmmendatins frm The Cancer Cuncil Australia The Cancer Cuncil Australia is Australia s peak nn-gvernment
More informationCDC Influenza Division Key Points MMWR Updates February 20, 2014
CDC Influenza Divisin Key Pints MMWR Updates In this dcument: Summary Key Messages Seasnal Influenza Vaccine Effectiveness: Interim Adjusted Estimates Influenza Surveillance Update: September 29, 2013-February
More informationBreast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)
Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages
More informationFor our protection, we require verification that you have received this notice. Therefore, please sign below.
PATIENT INFORMATION Dear Patient: Sleep prblems are extremely cmmn. Public health and safety are threatened by the increasing prevalence f bstructive sleep apnea, which nw afflicts at least 25 millin adults
More informationHEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.
HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING Public Health Relevance Cervical cancer is 90% preventable by having regular Papaniclau (Pap) tests. The Pap test, als knwn as a cervical smear,
More informationImaging tests allow the cancer care team to check for cancer and other problems inside the body.
IMAGING TESTS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between yu
More informationThe clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.
The clinical trial infrmatin prvided in this public disclsure synpsis is supplied fr infrmatinal purpses nly. Please nte that the results reprted in any single trial may nt reflect the verall ptential
More informationBRCA1 and BRCA2 Mutations
BRCA1 and BRCA2 Mutatins ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM v Cancer is a cmplex disease
More informationAccess to Heme Treatment in Canada - Survey 2018
Access t Heme Treatment in Canada - Survey 2018 The Canadian Assciatin fr Prphyria/Assciatin Canadienne de Prphyrie (CAP/ACP) asserts that patients with acute prphyria shuld have access t Hemin treatment,
More informationThe principles of evidence-based medicine
The principles f evidence-based medicine By the end f this mdule yu shuld be able t: Describe what evidence based medicine is Knw where t find quality evidenced based medicine n the internet Be able t
More informationOsteoporosis Fast Facts
Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased
More informationNeurological outcome from conservative or surgical treatment of cervical spinal cord injured patients
1993 nternatinal Medical Sciety f Paraplegia eurlgical utcme frm cnservative r surgical treatment f cervical spinal crd injured patients J E Kiwerski Spinal Department f Metrplitan Rehabilitatin Centre,
More informationYou may have a higher risk of bleeding if you take warfarin sodium tablets and:
MEDICATION GUIDE Warfarin (WAR-far-in) Sdium (SO-dee-um) Tablets USP The 7.5 mg tablets cntain FD&C Yellw N. 5 (tartrazine), which may cause allergic-type reactins (including brnchial asthma) in certain
More informationSignificance of Chronic Kidney Disease in 2015
1 Significance f Chrnic Kidney Disease in 2015 There is still a requirement within QOF t keep a register f peple with CKD stages 3-5. The ther CKD QOF targets have been retired. This is because CKD care
More informationDIRECTED FORGETIING: SHORT-TERM MEMORY OR CONDITIONED RESPONSE? WENDY S. MILLER and HARVARD L. ARMUS The University of Toledo
The Psychlgical Recrd, 1999, 49, 211-220 DIRECTED FORGETIING: SHORT-TERM MEMORY OR CONDITIONED RESPONSE? WENDY S. MILLER and HARVARD L. ARMUS The University f Tled Previus researchers have interpreted
More informationMedication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII)
Medicatin Guide MORPHINE SULFATE (mr-pheen) Oral Slutin (CII) IMPORTANT: Keep Mrphine Sulfate Oral Slutin in a safe place away frm children. Accidental use by a child is a medical emergency and can cause
More informationSwindon Joint Strategic Needs Assessment Bulletin
Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical
More informationFor our protection, we require verification that you have received this notice. Therefore, please sign below.
PATIENT INFORMATION Dear Patient: Sleep prblems are extremely cmmn. Public health and safety are threatened by the increasing prevalence f bstructive sleep apnea, which nw afflicts at least 25 millin adults
More informationTOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH
Tpic Circulatin list In case f query please cntact Executive Summary TOP TIPS Lung Cancer Update Dr Andrew Wight Cnsultant respiratry Physician - WUTH All Wirral GP s JaneFletcher2@nhs.net Dear Clleagues,
More informationWeight gain and height velocity during prolonged first remission from acute lymphoblastic. years and 15 for two years. Three patients who
Archives f Disease in Childhd, 1985, 60, 832-836 Weight gain and height velcity during prlnged first remissin frm acute lymphblastic leukaemia C P Q SAINSBURY, R G NEWCOMBE, AND I A HUGHES Departments
More information(Please text me on once you have submitted your request online and the cell number you used)
Dear Thank yu fr yur email, nted. Belw steps n hw t register as a service prvider. Please nte that nce yu have requested t becme a service prvider, yu need t sms/what s up me n 0826392585, in rder t activate
More informationQ 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?
updated 2012 Relaxatin training Q 5: Is relaxatin training better (mre effective than/as safe as) than treatment as usual in adults with depressive episde/disrder? Backgrund The number f general health
More informationCardiac Rehabilitation Services
Dcumentatin Guidance N. DG1011 Cardiac Rehabilitatin Services Revisin Letter A 1.0 Purpse The Centers fr Medicare and Medicaid Services (CMS) has detailed specific dcumentatin requirements fr Cardiac Rehabilitatin
More informationCDC Influenza Division Key Points November 7, 2014
In this dcument: Summary Key Messages FluView Activity Update LAIV Effectiveness and Vaccinatin f Children H3N2 Match and Vaccinatin Vaccine Supply Summary Key Messages This week s FluView reprt indicates
More informationRhinovirus infections
Pstgraduate Medical Jurnal (Nvember 1973) 49, 802-806. Rhinvirus infectins P. G. HGGNS Virus Reference Labratry, Central Public Health Labratry, Clindale Avenue, Lndn NW9 5HT Sunmary One hundred and seventy-five
More informationThe demonstration of lysosomes by the controlled temperature freezing-sectioning method By LUCILLE BITENSKY
205 The demnstratin f lyssmes by the cntrlled temperature freezing-sectining methd By LUCILLE BITESKY (Frm the Department f Pathlgy, Ryal Cllege f Surgens f England, Lincln's Inn Fields, Lndn, W.C. 2)
More informationObesity/Morbid Obesity/BMI
Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin
More informationAnnex III. Amendments to relevant sections of the Product Information
Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t
More informationSUICIDE AND MENTAL ILLNESS IN SINGAPORE
Vl. 15, N. 3. SINGAPORE MEDICAL JOURNAL 191 September, 1974. SUICIDE AND MENTAL ILLNESS IN SINGAPORE By W. F. Tsi and B. H. Chia SYNOPSIS This is a study f 112 cases f suicides wh had a past histry f being
More informationHuman papillomavirus (HPV) refers to a group of more than 150 related viruses.
HUMAN PAPILLOMAVIRUS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between
More informationCoronary Artery Disease (CAD): Beta Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) (NQF 0070)
Crnary Artery Disease (CAD): Beta Blcker Therapy fr CAD Patients with Prir Mycardial Infarctin (MI) (NQF 0070) EMeasure Name Crnary Artery Disease EMeasure Id Pending (CAD): Beta Blcker Therapy fr CAD
More informationPodcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10
Pdcast Transcript Title: Cmmn Miscding f LARC Services Impacting Revenue Speaker Name: Ann Finn Duratin: 00:16:10 NCTCFP: Welcme t this pdcast spnsred by the Natinal Clinical Training Center fr Family
More informationThe Mental Capacity Act 2005; a short guide for the carers and relatives of those who may need support. Ian Burgess MCA Lead 13 February 2017
The Mental Capacity Act 2005; a shrt guide fr the carers and relatives f thse wh may need supprt Ian Burgess MCA Lead 13 February 2017 Agenda Overview f the MCA The 5 Principles and the legal definitin
More informationChapter 6: Impact Indicators
Overview Chapter 6: Impact Indicatrs The best measure f the lng-term impact f all HIV preventin activities is the HIV incidence rate, namely the number f new cases f HIV infectin per year divided by the
More informationCONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS
CONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS Yu want t take teststerne t masculinize yur bdy. Befre taking it, there are several things yu need t knw abut. They are the pssible advantages, disadvantages,
More informationBP Thresholds for Medical Review
BP Threshlds fr Medical Review Wmen presents t GP pstnatally with high bld pressure r referred t GP by midwife GP t review patient n the same day if BP>150/100. If BP (dne by midwife) persistently 140-149/90-99,
More informationThe estimator, X, is unbiased and, if one assumes that the variance of X7 is constant from week to week, then the variance of X7 is given by
ESTIMATION PROCEDURES USED TO PRODUCE WEEKLY FLU STATISTICS FROM THE HEALTH INTERVIEW SURVEY James T. Massey, Gail S. Pe, Walt R. Simmns Natinal Center fr Health Statistics. INTRODUCTION In April 97, the
More informationVaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE
Vaccine Infrmatin Statement: PNEUMOCOCCAL CONJUGATE VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están
More informationNFS284 Lecture 3. How much of a nutrient is required to maintain health? Types and amounts of foods to maintain health
NFS284 Lecture 3 Chapter 2: Nutritin: Guidelines: Applying the Science f Nutritin 2.1 Nutritin Recmmendatin fr the Canadian Diet Nutrient-based apprach Hw much f a nutrient is required t maintain health?
More informationSuccess Criteria: Extend your thinking:
Discussin Directr Yur jb is t invlve thers in cnversatin abut the text by getting them t think and talk abut the BIG IDEAS in the chapter/ sectin they have just read. Cmpse 5 questins that yu want t discuss
More information1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT
WOMEN AND NEWBORN HEALTH SERVICE CLINICAL GUIDELINES SECTION A: GUIDELINES RELEVANT TO OBSTETRICS AND GYNAECOLOGY 1 STANDARD PROTOCOLS 1.11 INSULIN INFUSION PUMP MANAGEMENT - INPATIENT Authrised by: OGCCU
More informationLTCH QUALITY REPORTING PROGRAM
4 LTCH QUALITY REPORTING PROGRAM GENERAL INFORMATION...3 LTCH FACILITY-LEVEL QUALITY MEASURE REPORT...5 LTCH PATIENT-LEVEL QUALITY MEASURE REPORT...18 LTCH REVIEW AND CORRECT REPORT...23 09/2018 v1.04
More informationCompleting the NPA online Patient Safety Incident Report form: 2016
Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject
More informationMETHYL TESTOSTERONE IN PREMATURE INFANTS
METHYL TESTOSTERONE IN PREMATURE INFANTS BY URSULA JAMES and B. L. COLES Frm the General Lying-In and Annie McCall Hspitals, Lndn (RECE:IVED FOR PUBLICATiN crber 18. 195 1) It is an established fact that
More informationMonensin and Extruded Urea-Grain for Range Beef Cows
Mnensin and Extruded Urea-Grain fr Range Beef Cws R. P. Lemenager, F. N. Owens, w. E. Sharp, Merwin Cmptn and Rbert Ttusek Stry in Brief Tw trials were cnducted t evaluate the supplemental value f mnensin
More informationdetailed in Ward and Lockhead (1970), is only summarized here.
Respnse system prcesses in abslute judgment* LAWRENCE M. WARDt and G. R. LOCKHEAD Duke University, Durham, Nrth Carlina 2778 Cnsistent relatinships are fund between Ss' abslute judgments f the value f
More informationThe effects of a two-school. school-year. back education program. in elementary schoolchildren
IEA Maastricht - 12 July 2006 The effects f a tw-schl schl-year multi-factrial back educatin prgram in elementary schlchildren Drs Elisabeth Geldhf Prf Dr D De Clercq Prf Dr I De Burdeaudhuij Prf Dr G
More informationACSQHC National Consensus Statement: Essential Elements for High Quality End-oflife Care in Acute Hospitals.
27 March 2014 Prfessr Debra Picne Chief Executive Officer Australian Cmmissin n Safety and Quality in Health Care c/ Ms Jennifer Hill, Senir Prject Officer Level 5, 255 Elizabeth Street SYDNEY NSW 2000
More informationInterpretation. Historical enquiry religious diversity
Name: Year 8 Histry Prject 3: D The Cmmnwealth Games Still Matter In The 21 st Century? Mdule: Date Set: Deadline: Descriptin f the task: The prject is split int three separate parts: The prject is split
More informationMEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion
MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injectin fr intravenus infusin Read this Medicatin Guide befre yu start receiving LEMTRADA and befre yu begin each treatment curse. There may be new
More informationHow to become an AME Online
Hw t becme an AME Online 1. Check that yu meet the minimum technical requirements in rder t use the AME Online system: Operating System: Windws Vista (Service Pack 2) Windws 7 Windws 8, 8.1 Windws 10 Please
More informationAdult Preventive Care Guidelines
Adult Preventive Care Guidelines Gundersen is yur partner fr better health. We want t wrk with yu t make sure that yu and yur family are as healthy as pssible. That can be accmplished best if we wrk tgether
More informationInfluenza (Flu) Fact Sheet
Influenza (Flu) Fact Sheet What is the flu? The flu is a cntagius respiratry illness caused by influenza viruses. It can cause mild t severe illness, and at times can lead t death. Sme peple, such as lder
More informationPackage leaflet: Information for the user. Fragmin Graduated Syringe 10,000 IU/ml Solution for Injection dalteparin sodium
Package leaflet: Infrmatin fr the user Fragmin Graduated Syringe 10,000 IU/ml Slutin fr Injectin dalteparin sdium Read all f this leaflet carefully befre yu start using this medicine because it cntains
More informationPackage leaflet: Information for the user. Fragmin 10,000 IU/1 ml and 10,000 IU/4 ml Solution for injection dalteparin sodium
Package leaflet: Infrmatin fr the user Fragmin 10,000 IU/1 ml and 10,000 IU/4 ml Slutin fr injectin dalteparin sdium Read all f this leaflet carefully befre yu start using this medicine because it cntains
More informationMEDICATION GUIDE. (canagliflozin) Tablets
MEDICATION GUIDE INVOKANA (in-v-kahn-uh) (canagliflzin) Tablets What is the mst imprtant infrmatin I shuld knw abut INVOKANA? INVOKANA can cause imprtant side effects, including: Dehydratin. INVOKANA can
More informationCancer Association of South Africa (CANSA)
Cancer Assciatin f Suth Africa (CANSA) Fact Sheet and Psitin Statement n Cannabis in Suth Africa Intrductin Cannabis is a drug that cmes frm Indian hemp plants such as Cannabis sativa and Cannabis indica.
More informationPackage leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate
Package leaflet: Infrmatin fr the user Daceptn 5 mg/ml Slutin fr infusin Apmrphine hydrchlride hemihydrate Read all f this leaflet carefully befre yu start using this medicine because it cntains imprtant
More informationCode of employment practice on infant feeding
Cde f emplyment practice n infant feeding An Emplyer s guide t: Sectin 69Y f the Emplyment Relatins Act 2000 Frewrd As Minister f Labur, I am pleased t publish the Cde f Emplyment Practice n Infant Feeding.
More informationTABLE OF CONTENTS Glossary of terms Code Pad Diagram 3. Understanding the Code Pad lights.4.
TABLE OF CONTENTS... Glssary f terms 2... Cde Pad Diagram 3 Understanding the Cde Pad lights.4 Cde Pad tnes 5 Fully arming the system - ON MODE 6 Fully arming the system - Quick Arm MODE 6 Partially arming
More informationUnderstanding and Recognizing Anxiety
Understanding and Recgnizing Anxiety Mst peple d nt recgnize their anxiety fr what it is, and instead think there is smething mre serius ging n. Myth: Reading, thinking, and learning abut anxiety will
More informationCONSENT FOR KYBELLA INJECTABLE FAT REDUCTION
CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,
More informationData Fusion for Predicting Breast Cancer Survival
Data Fusin fr Predicting Breast Cancer Linbailu Jiang, Yufei Zhang, Siyi Peng Mentr: Irene Kaplw December 11, 2015 1 Intrductin 1.1 Backgrund Cancer is mre f a severe health issue than ever in ur current
More informationGlaucoma Interviews: Due Tuesday, May 22 nd
Glaucma Interviews: Due Tuesday, May 22 nd 1) Read the glaucma article well! It will explain what it is, plus tell yu sme symptms and risk factrs. Yu may want t use a highlighter r pen t mark imprtant
More information2017 Optum, Inc. All rights reserved BH1124_112017
1) What are the benefits t clients f encuraging the use f MAT? Withut MAT, 90% f individuals with Opiid Use Disrder (OUD) will relapse within ne year. With MAT, the relapse rate fr thse with OUD decreases
More informationMEDICATION GUIDE. (fingolimod) capsules
MEDICATION GUIDE GILENYA (je-len-yah) (finglimd) capsules Read this Medicatin Guide befre yu start using GILENYA and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take the
More information23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)
Intrductin & Aims Drug and Alchl Cnsultatin Liaisn (AOD CL) services aim t imprve identificatin and treatment f patients with AOD mrbidity. The csts and cnsequences f targeting AOD patients presenting
More informationPost Distribution Monitoring Report
Pst Distributin Mnitring Reprt Hygiene Kit funded by IMC Backgrund Infrmatin Lcatin: Zaatari Camp (All districts) Dates f data cllectin: 1-2 f Octber, 2014 Objective: t understand t what extent the distributin
More informationBedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review:
Bedfrdshire and Hertfrdshire DRAFT Pririties frum statement Number: Subject: Prstatism Date f decisin: January 2010 Date f review: Referral criteria Mst men with lwer urinary tract symptms due t benign
More informationPILI Ohana Facilitator s Guide
Previus Versin: September 10, 2007 Updated Versin: Octber 2, 2007 PILI Ohana Facilitatr s Guide Lessn 5: Managing and Reducing Negative Thughts and Emtins. Questin/Tpic Script Reminder/Activity Welcming
More informationMedication Guide SIGNIFOR [sig-na-for] (pasireotide) Injection
Medicatin Guide SIGNIFOR [sig-na-fr] (pasiretide) Injectin Read this Medicatin Guide befre yu start using SIGNIFOR and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take
More informationSimilar effects of hydrochlorothiazide and spironolactone on plasma renin activity in essential hypertension
Similar effects f hydrchlrthiazide and spirnlactne n plasma renin activity in essential hypertensin Sergi Acchiard, M.D.* Harriet P. Dustan, M.D., Rbert C. Tarazi, M.D. Research Divisin Thiazide diuretics
More informationA Plasma Humoral Factor of Extrarenal Origin Causing Release of Reninlike Activity in Hypotensive Dogs
A Plasma Humral Factr f Extrarenal Origin Causing Release f Reninlike Activity in Hyptensive Dgs By E. De Vit, C. Wilsn, R. E. Shipley, R. P. Miller, and B. L. Mrtx ABSTRACT Plasma reninlike activity significantly
More informationCRANIOFACIAL RESECTION
CRANIOFACIAL RESECTION This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins
More informationA RECENT INVESTIGATION 7 of methods for determination of ovulation suggested
The Relatin f Urine V lume t the Menstrual Cycle and Ovulatin WAYNE L. RYAN, PH.D., ROBERT J. LUBY, M.D., AND MICHAEL J. HALLER, A.B. A RECENT INVESTIGATION 7 f methds fr determinatin f vulatin suggested
More informationLee County Florida Income Guideline Chart
NEIGHBORHOOD STABILIZATION PROGRAM OF LEE COUNTY BUYER-RELATED QUESTIONS 1. Why is NSP beneficial t yur buyers? Three key advantages make the NSP Prgram especially attractive t eligible buyers: 1) Investrs
More informationIndividual Assessments for Couples Treatment with HFCA
Individual Assessments fr Cuples Treatment with HFCA Jennifer S. Ripley, Ph.D. Many appraches t cuples therapy include an individual assessment whenever a cuple cmes fr treatment. Therapists shuld be aware
More informationHead and neck cancers are often treated with radiotherapy. Radiotherapy can lead to faster rates of tooth decay and poor healing in the mouth.
DENTAL EXTRACTION This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins that
More informationCircadian Changes in Plasma Renin Activity and Plasma Aldosterone Concentration in Two-Kidney Hypertensive Rats
Circadian Changes in Plasma Renin Activity and Plasma Aldsterne Cncentratin in Tw-Kidney Hypertensive Rats JACK M. DEFORREST, PH.D., JAMES O. DAVIS, PH.D., M.D., RONALD H. FREEMAN, PH.D., GREGORY A. STEPHENS,
More informationThe data refer to persons aged between 15 and 54.
Drug-related hspital stays in Australia 1993-2005 Prepared by Amanda Rxburgh and Luisa Degenhardt, Natinal Drug and Alchl Research Centre Funded by the Australian Gvernment Department f Health and Ageing
More informationUnderstanding Blood Counts
Understanding Bld Cunts PMH This pamphlet is fr patients at Princess Margaret Hspital. It will help yu t read and understand the bld cunt infrmatin yu get frm the bld lab. Patient Educatin Imprving Health
More informationModule 6: Goal Setting
Mdule 6: Gal Setting Objectives T understand the cncept f gal setting in Brief CBT T acquire skills t set feasible and apprpriate gals in Brief CBT What is gal setting, and why is it imprtant t set gals
More informationWound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018
Wund Care Equipment and Supply Benefits t Change fr Texas Medicaid July 1, 2018 Infrmatin psted May 11, 2018 Nte: Texas Medicaid managed care rganizatins (MCOs) must prvide all medically necessary, Medicaid-cvered
More informationPain relief after surgery
Pain relief after surgery Imprtant infrmatin fr patients www.mchft.nhs.uk We care because yu matter This leaflet is designed t help yu cntrl any pain yu may have at hme fllwing yur peratin. Please read
More informationFOUNDATIONS OF DECISION-MAKING...
Table f Cntents FOUNDATIONS OF DECISION-MAKING... Errr! Bkmark nt Describe the decisin-making prcess pp.62-66... Errr! Bkmark nt Explain the three appraches managers can use t make decisins pp.67-70 Errr!
More informationCONGENITAL NASOLACRIMAL DUCT OBSTRUCTION IN THE SECOND YEAR OF LIFE: A MULTI CENTRE TRIAL OF MANAGEMENT
CONGENITAL NASOLACRIMAL DUCT OBSTRUCTION IN THE SECOND YEAR OF LIFE: A MULTI CENTRE TRIAL OF MANAGEMENT J. D. H. YOUNG\ c. J. MacEWEN! and S. A. OGSTON Dundee Cllabrating surgens: G. J. Bedfrd, Dumfries;
More information2019 Canada Winter Games Team NT Female Hockey Selection Camp August 16-19, 2018
2019 Canada Winter Games Team NT Female Hckey Selectin Camp August 16-19, 2018 Strength and Cnditining Recmmendatins As discussed in the Call Fr Players letter, it is critical fr players t get their bdies
More informationFood information to consumers - Commission proposal - COM (2008) 40 final 2008/0028 (COD) The European Heart Network s position in a nutshell
Fd infrmatin t cnsumers - Cmmissin prpsal - COM (2008) 40 final 2008/0028 (COD) The Eurpean Heart Netwrk s psitin in a nutshell Summary On 30 January 2008 the Eurpean Cmmissin published its prpsal fr a
More informationSugar Rush: The Science of Sweet
Sugar Rush: The Science f Sweet FRAMEWORK I. Scientific and Engineering Practices II. Crss-Cutting Cncepts III. Physical Sciences SKILLS/OBJECTIVES T bserve the results f hands-n experiments and make inferences/draw
More informationA pre-conference should include the following: an introduction, a discussion based on the review of lesson materials, and a summary of next steps.
NAU Mdel Observatin Prtcl The mdel prtcl was develped with supprt and expertise frm the Natinal Institute fr Excellence in Teaching (NIET) and is based in great part n NIET s extensive experience cnducting
More informationMeeting Minutes. III. New Business (Slide Presentation is embedded for reference) [slides 3-47] May 2011 DMRAB Presentation PUBLIC C
Cmmnwealth f Kentucky Cabinet fr Health and Family Services Department fr Medicaid Services Drug Management Review Advisry Bard Meeting May 12, 2011 Meeting Minutes Vting Members in attendance: Kim Crley,
More informationCONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW
FACT SHEET CONTACT: Amber Hamiltn 212-266-0062 TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW Type 2 diabetes accunts fr 90-95% f the 29.1 millin diabetes cases in the U.S. 1 Obesity is a majr independent
More informationFOLLOW-UP IN-DEPTH INTERVIEW GUIDELINES
Appendix h STUDY NUMBER: COST OF UNSAFE ABORTION FOLLOW-UP IN-DEPTH INTERVIEW GUIDELINES T be administered abut 2-3 weeks after leaving the health facility 1. IDENTIFICATION 101. Patient identificatin
More information